Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
29%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
2
22%
Ph not_applicable
4
44%
Ph phase_1
2
22%
Ph phase_3
1
11%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (22.2%)
Phase 22 (22.2%)
Phase 31 (11.1%)
N/A4 (44.4%)

Trials by Status

completed778%
terminated111%
unknown111%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_3

Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting

NCT04297813
completednot_applicable

MagnetOs™ Granules vs. Autograft in Instrumented Posterolateral Spinal Fusion

NCT03625544
completednot_applicable

The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction

NCT04533880
unknownphase_2

KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion

NCT04294004
terminatedphase_1

Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion

NCT00797550
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04297813Phase 3

Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting

Completed
NCT03625544Not Applicable

MagnetOs™ Granules vs. Autograft in Instrumented Posterolateral Spinal Fusion

Completed
NCT04533880Not Applicable

The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction

Completed
NCT04294004Phase 2

KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion

Unknown
NCT00797550Phase 1

Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion

Terminated
NCT01982045Not Applicable

RCT of AttraX® Putty vs. Autograft in Instrumented Posterolateral Spinal Fusion

Completed
NCT01305356Not Applicable

Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions

Completed
NCT01690260Phase 1

Parallel Study Between BMP-2 and Autologous Bone Graft After Ilizarow Treatment

Completed
NCT01813188Phase 2

Clinical Trial Based on the Use of Mononuclear Cells From Autologous Bone Marrow in Patients With Pseudoarthrosis

Completed

All 9 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
9